Possible role of protein kinase-dependent smooth muscle contractile mechanism in the occurrence of delayed spasm after subarachnoid hemorrhage

蛋白激酶依赖性平滑肌收缩机制在蛛网膜下腔出血后迟发性痉挛发生中的可能作用

基本信息

  • 批准号:
    10671316
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

We have already reported the following experimental evidence suggesting that PKC (protein kinase C) activation participates in the occurrence of chronic vasospasm following subarachnoid hemorrhage. 1] The canine basilar artery (BA) possesses a PKC system which fully functions even in the Ca^<2+>-free medium, and that the narrowing or the augmented tonus of the BA exposed to 'two-hemorrhage' can be reversed by application of PKC inhibitors such as H-7 and staurosporine either in vivo or in vitro condition. 2] The content of 1,2-diacylglycerol, an intrinsic PKC activator, is significantly increased through the stimulated turnover of phosphatidylcholine and phosphatidylethanolamine in the spastic BA in comparison with that in the nonspastic BA.3] In spastic arteries at Days 4 and 7, the cytosolic PKC activity showed a decrease of 40-45% with no significant changes in membrane PKC activity as compared with nonspastic control arteries. The extent of 20 kDa myosin light chain phosphorylation … More was unchanged between the spastic and nonspastic BA.On Day 14, the cytosolic PKC activity of arteries returned toward the normal control level with the remission of vasospasm. Western blot analysis of the PKC isoforms revealed that the amounts of PKCα and PKCε but not PKCζ were down-regulated in spastic arteries, suggesting the activation of PKCα and PKCε in the course of chronic vasospasm. 4] The augmentation of active smooth muscle contraction, possibly induced by PKC activation, plays a role in the occurence of chronic vasospasm which is more important than the altered passive physical properties of the arterial wall (decreased dispensability of arterial wall). 5] In addition, it is revealed that oxidized diacylglycerol induces sustained contraction of normal and skinned BA.Under the pCa=5.5, an incubation of skinned basilar artery with palmitoyl-arachidonyl diacylglycerol-hydroperoxide (5xl0^<-5>M) shows a remarkable down-regulation of PKC a and e. As it is known that the down-regulation of the protein is the direct evidence to show its preceding activation, the oxidized-diacylglycerol induced contraction is thought to be mediated by an activation of PKC a orε. 6] Finally, PAG=OH and PLG-OH as an oxidized DAG were found in the brain tissue subjected to experimental subarachnoid hemorrhage. The above line of investigations render it likely that PKC activation, especially type e which is though to play a central role in the calciun-independent mechanism of smooth muscle contraction, participates in the occurrence of chronic vasospasm following subarachnoid hemorrhage Less
我们已经报道了以下实验证据,表明PKC(蛋白激酶C)激活参与蛛网膜下腔出血后慢性血管痉挛的发生。1]犬基底动脉(BA)具有一个PKC系统,即使在无Ca^2+的介质中也能充分发挥其功能,并且在体内或体外条件下应用PKC抑制剂如H-7和星形孢菌素(staurosporine)可逆转“二次出血”引起的BA狭窄或张力增强。2]与非痉挛性BA相比,痉挛性BA中的磷脂酰胆碱和磷脂酰乙醇胺的刺激周转显著增加了内源性PKC激活剂1,2-二酰甘油的含量。[3]在痉挛性动脉中,与非痉挛性对照动脉相比,在第4和第7天,胞浆PKC活性显示出40-45%的下降,而膜PKC活性没有显著变化。20 kDa肌球蛋白轻链磷酸化程度 ...更多信息 在第14天,随着血管痉挛的缓解,动脉细胞浆PKC活性恢复到正常对照水平。Western blot分析显示,在痉挛血管中PKCα和PKCε表达下调,而PKC β表达无明显变化,提示PKCα和PKCε在慢性血管痉挛过程中激活。4]可能由PKC激活引起的主动平滑肌收缩的增强在慢性血管痉挛的发生中起作用,这比动脉壁的被动物理性质改变(动脉壁的可分配性降低)更重要。5]在pCa=5.5时,用棕榈酰-花生四烯酰二酰基甘油-氢过氧化物(5 × 10 - 4 M)孵育带皮基底动脉<-5>,显示PKC α和e的显著下调。由于已知蛋白质的下调是显示其先前激活的直接证据,因此认为氧化二酰甘油诱导的收缩是由PKC α或ε的激活介导的。6]最后,PAG=OH和PLG-OH作为氧化DAG被发现在实验性蛛网膜下腔出血的脑组织中。上述研究表明,PKC激活,特别是在平滑肌收缩的钙非依赖性机制中发挥核心作用的e型PKC激活,可能参与蛛网膜下腔出血后慢性血管痉挛的发生。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mori T,Matsui T et al: "Possible role of the superoxide anion in the development of neuronal tolerance following ischaemic preconditioning in rats"Neuropathol.& Appl.Neurobiol.. 26. 131-140 (2000)
Mori T、Matsui T 等人:“超氧阴离子在大鼠缺血预处理后神经元耐受性发展中的可能作用”Neuropathol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
谷口民樹,松居徹 他: "実験的局所永久脳虚血に対する脳冷却法の効果"脳循環代謝. 12. 438-439 (2000)
Tamiki Taniguchi、Toru Matsui 等人:“脑冷却对实验性局灶性永久性脑缺血的影响”《脑循环与代谢》12. 438-439 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
森本正,松居徹 他: "側方到達法による上位頚髄手術"脊髄外科. 14. 95-101 (2000)
Tadashi Morimoto、Toru Matsui 等人:“使用侧向入路的上颈脊髓手术”脊柱外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asano T, Matsui T.: "The Ameliorative Effect Of ONO-2506 On The Delayed And Prolonged Expansion Of The Infarct Volume Following Permanent Middle Cerebral Artery Occlusion In Rats"J of CBF and Metabol. suppl19. s64 (1999)
Asano T、Matsui T.:“ONO-2506 对大鼠永久性大脑中动脉闭塞后梗塞体积延迟和延长扩张的改善作用”J of CBF and Metabol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asano T,Matsui T,: "Various pathogenic factors revolving around the central role of protein kinase C activation in the occurrence of cerebral" Critical Review Neurosurg. 8. 176-187 (1998)
Asano T,Matsui T,:“各种致病因素围绕蛋白激酶 C 激活在脑卒中发生中的核心作用”神经外科批判评论。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUI Toru其他文献

MATSUI Toru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUI Toru', 18)}}的其他基金

Degradative matrix construction with aromatic condensed heterocyclic compounds by petroleum desulfurizing and PAH degrading bacteria, and its application for bioremediation.
石油脱硫多环芳烃降解菌构建芳香稠合杂环化合物降解基质及其生物修复应用
  • 批准号:
    17K08173
  • 财政年份:
    2017
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Computational study on the correlation between out-of-plane mode of heme and redox potential
血红素面外模式与氧化还原电位相关性的计算研究
  • 批准号:
    26810012
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Generic technology for halophilic bacteria using genomic data from next genearation sequencer
使用下一代测序仪的基因组数据的嗜盐细菌通用技术
  • 批准号:
    23580117
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
POSSIBLE PARTICIPATION OF NITRIC OXIDE IN THR PATHOGRNESIS UNDERLYING ISCHEMIC CEREBRAL DAMAGE
一氧化氮可能参与缺血性脑损伤的发病机制
  • 批准号:
    07457323
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ROLE OF NITRIC OXIDE IN PATHOGENESIS UNDERLYING ISCHEMIC BRAIN DAMAGE
一氧化氮在缺血性脑损伤发病机制中的作用
  • 批准号:
    05671181
  • 财政年份:
    1993
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Aberrant Protein Kinase C Signaling in Alzheimer's Disease
阿尔茨海默病中的异常蛋白激酶 C 信号转导
  • 批准号:
    10901015
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation of Protein Kinase C Theta by Phosphorylation
通过磷酸化调节蛋白激酶 C Theta
  • 批准号:
    10679152
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
RUI: Protein-Protein Interactions of Protein Kinase C During Polarized Growth in Filamentous Fungi
RUI:丝状真菌极化生长过程中蛋白激酶 C 的蛋白质-蛋白质相互作用
  • 批准号:
    2222841
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Continuing Grant
Protein kinase C and lung carcinogenesis
蛋白激酶C与肺癌发生
  • 批准号:
    10733467
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Protein kinase C signaling in prostate cancer health disparities
前列腺癌健康差异中的蛋白激酶 C 信号传导
  • 批准号:
    10744533
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Effectors of protein kinase C-mediated tumor progression
蛋白激酶 C 介导的肿瘤进展的效应器
  • 批准号:
    10543367
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation of placental epithelial cell death by atypical protein kinase-c
非典型蛋白激酶-c对胎盘上皮细胞死亡的调节
  • 批准号:
    573074-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    University Undergraduate Student Research Awards
Structural optimization of vibsanins with scaffold diversity as protein kinase C activator
具有支架多样性的 vibsanins 作为蛋白激酶 C 激活剂的结构优化
  • 批准号:
    22K05464
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of trophoblast stem cell homeostasis and differentiation by atypical protein kinase-C isoforms
非典型蛋白激酶-C 亚型对滋养层干细胞稳态和分化的调节
  • 批准号:
    RGPIN-2021-02807
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Discovery Grants Program - Individual
Regulation of trophoblast stem cell homeostasis and differentiation by atypical protein kinase-C isoforms
非典型蛋白激酶-C 亚型对滋养层干细胞稳态和分化的调节
  • 批准号:
    RGPIN-2021-02807
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了